Siga Technologies INC Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Siga Technologies INC (SIGA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.64 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-10
- Siga Technologies INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $2.64K, a 88.01% decline from fiscal 2024.
- Siga Technologies INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $22.00K, a 47.62% decline from fiscal 2023.
- Siga Technologies INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $42.00K.
- Siga Technologies INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was -$24.87K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $2.64K 10-K · filed 2026-03-10 |
| 2024-12-31 | $22.00K 10-K · filed 2025-03-11 |
| 2023-12-31 | $42.00K 10-K · filed 2024-03-12 |
| 2020-12-31 | -$24.87K 10-K · filed 2021-03-04 |
| 2018-12-31 | $101.50M 10-K · filed 2020-03-05 |
| 2017-12-31 | $53.00M 10-K · filed 2018-03-06 |
| 2016-12-31 | $11.90M 10-K · filed 2017-03-07 |
| 2015-12-31 | $10.90M 10-K · filed 2016-03-04 |
| 2014-12-31 | $128.10M 10-K · filed 2015-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |